Similar findings were observed in another large laboratory-based study, though overall PV detection rates were lower due to a larger proportion of unaffected patients.20 Together, these findings support the revision of BRCA1/2 and Lynch syndrome testing criteria to include a broader spectrum of cancer predisposition genes, particularly those with consensus management recommendations and overlapping phenotypes. This evidence concerns the gene BRCA1 and Lynch syndrome.